Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy

被引：26

作者：

Ghesquieres, H ^{[1
]}

机构：

[1] Ctr Leon Berard, F-69008 Lyon, France

来源：

ANNALS OF ONCOLOGY | 2005年 / 16卷 / 08期

关键词：

D O I：

10.1093/annonc/mdi232

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1399 / 1399

页数：1

共 5 条

[1] Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species [J].

Bellosillo, B ;

Villamor, N ;

López-Guillermo, A ;

Marcé, S ;

Esteve, J ;

Campo, E ;

Colomer, D ;

Montserrat, E .

BLOOD, 2001, 98 (09) :2771-2777

[2]

Bienvenu J, 2001, Hematol J, V2, P378, DOI 10.1038/sj.thj.6200133

[3]

Burton C, 2003, NEW ENGL J MED, V348, P2690

[4] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].

Coiffier, B ;

Lepage, E ;

Brière, J ;

Herbrecht, R ;

Tilly, H ;

Bouabdallah, R ;

Morel, P ;

Van den Neste, E ;

Salles, G ;

Gaulard, P ;

Reyes, F ;

Gisselbrecht, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242

[5] Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma:: The LNH87-1 study [J].

Tilly, H ;

Mounier, N ;

Lederlin, P ;

Brière, J ;

Dupriez, B ;

Sebban, C ;

Bosly, A ;

Biron, P ;

Nouvel, C ;

Herbrecht, R ;

Bordessoule, D ;

Coiffier, B .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) :1309-1315

← 1 →